Banned drugs: Still available in India

Drugs undergo rigorous testing before they are introduced into the market. The efficacy as well as safety profiles of the drug are tested, adverse effects of drugs appear only after the drug is used in the general population. These adverse effects are detected through pharmacovigilance. If the adver...

Full description

Saved in:
Bibliographic Details
Published in:Journal of Indian Academy of Oral Medicine and Radiology 2011-07, Vol.23 (5), p.380-381
Main Authors: Gupta, Manjari, Ghom, Anil, Debta, F, Vyas, Sunil, Deoghare, Abhijeet, Gupta, Prashant, Gupta, Shantala
Format: Article
Language:English
Subjects:
Banned drugs
Drugs
Mandatory drug testing
Pharmacovigilance
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 381
container_issue 5
container_start_page 380
container_title Journal of Indian Academy of Oral Medicine and Radiology
container_volume 23
creator Gupta, Manjari
Ghom, Anil
Debta, F
Vyas, Sunil
Deoghare, Abhijeet
Gupta, Prashant
Gupta, Shantala
description Drugs undergo rigorous testing before they are introduced into the market. The efficacy as well as safety profiles of the drug are tested, adverse effects of drugs appear only after the drug is used in the general population. These adverse effects are detected through pharmacovigilance. If the adverse effects are severe or the risks of using the drug outweigh the benefits, the country bans the drug. Some drugs may cause adverse effects only when combined with particular drugs. In such cases, only the fixed dose combination is banned and not the individual drugs. This article is related to banned drugs and the products which are still used in medical fraternity.
doi_str_mv 10.5005/jp-journals-10011-1174
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_ed916fcf640d4bcd95cd37ac0cea3c3d</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A745196686</galeid><doaj_id>oai_doaj_org_article_ed916fcf640d4bcd95cd37ac0cea3c3d</doaj_id><sourcerecordid>A745196686</sourcerecordid><originalsourceid>FETCH-LOGICAL-c281t-6d1a4ea89d554cda7ff2fd36ae625d88cbe71ee61b3582d13997822c6b968c93</originalsourceid><addsrcrecordid>eNptjEtLAzEUhYMoWKt_QQaE7lKTyeTlrhYfhYILux_u5CZtSjpTZqaC_96hdVFB7uJcDt_5CLnnbCoZk4_bPd02h7aG1FHOGOeUc11ckBGzWlIudX55_HPKhRLX5KbrtoyporByRCbPUNceM2wP6-4p--xjShl8QUxQJZ_FOlvUGOGWXIXB7-9-c0xWry-r-Ttdfrwt5rMldbnhPVXIofBgLEpZOAQdQh5QKPAql2iMq7zm3iteCWly5MJabfLcqcoq46wYk8VJiw1sy30bd9B-lw3E8lg07bqEto8u-dKj5Sq4oAqGReXQSodCg2POg3ACB9fDybWGAY91aPoW3C52rpzpQnKrlFEDNf2HGg79Lrqm9iEO_Z_B5Gyw8ZD6TdekQx-bujsHfwCB0npp</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Banned drugs: Still available in India</title><source>Medknow Open Access Medical Journals(OpenAccess)</source><source>Publicly Available Content Database</source><creator>Gupta, Manjari ; Ghom, Anil ; Debta, F ; Vyas, Sunil ; Deoghare, Abhijeet ; Gupta, Prashant ; Gupta, Shantala</creator><creatorcontrib>Gupta, Manjari ; Ghom, Anil ; Debta, F ; Vyas, Sunil ; Deoghare, Abhijeet ; Gupta, Prashant ; Gupta, Shantala</creatorcontrib><description>Drugs undergo rigorous testing before they are introduced into the market. The efficacy as well as safety profiles of the drug are tested, adverse effects of drugs appear only after the drug is used in the general population. These adverse effects are detected through pharmacovigilance. If the adverse effects are severe or the risks of using the drug outweigh the benefits, the country bans the drug. Some drugs may cause adverse effects only when combined with particular drugs. In such cases, only the fixed dose combination is banned and not the individual drugs. This article is related to banned drugs and the products which are still used in medical fraternity.</description><identifier>ISSN: 0972-1363</identifier><identifier>EISSN: 0975-1572</identifier><identifier>DOI: 10.5005/jp-journals-10011-1174</identifier><language>eng</language><publisher>Medknow Publications and Media Pvt. Ltd</publisher><subject>Banned drugs ; Drugs ; Mandatory drug testing ; Pharmacovigilance</subject><ispartof>Journal of Indian Academy of Oral Medicine and Radiology, 2011-07, Vol.23 (5), p.380-381</ispartof><rights>COPYRIGHT 2011 Medknow Publications and Media Pvt. Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids></links><search><creatorcontrib>Gupta, Manjari</creatorcontrib><creatorcontrib>Ghom, Anil</creatorcontrib><creatorcontrib>Debta, F</creatorcontrib><creatorcontrib>Vyas, Sunil</creatorcontrib><creatorcontrib>Deoghare, Abhijeet</creatorcontrib><creatorcontrib>Gupta, Prashant</creatorcontrib><creatorcontrib>Gupta, Shantala</creatorcontrib><title>Banned drugs: Still available in India</title><title>Journal of Indian Academy of Oral Medicine and Radiology</title><description>Drugs undergo rigorous testing before they are introduced into the market. The efficacy as well as safety profiles of the drug are tested, adverse effects of drugs appear only after the drug is used in the general population. These adverse effects are detected through pharmacovigilance. If the adverse effects are severe or the risks of using the drug outweigh the benefits, the country bans the drug. Some drugs may cause adverse effects only when combined with particular drugs. In such cases, only the fixed dose combination is banned and not the individual drugs. This article is related to banned drugs and the products which are still used in medical fraternity.</description><subject>Banned drugs</subject><subject>Drugs</subject><subject>Mandatory drug testing</subject><subject>Pharmacovigilance</subject><issn>0972-1363</issn><issn>0975-1572</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNptjEtLAzEUhYMoWKt_QQaE7lKTyeTlrhYfhYILux_u5CZtSjpTZqaC_96hdVFB7uJcDt_5CLnnbCoZk4_bPd02h7aG1FHOGOeUc11ckBGzWlIudX55_HPKhRLX5KbrtoyporByRCbPUNceM2wP6-4p--xjShl8QUxQJZ_FOlvUGOGWXIXB7-9-c0xWry-r-Ttdfrwt5rMldbnhPVXIofBgLEpZOAQdQh5QKPAql2iMq7zm3iteCWly5MJabfLcqcoq46wYk8VJiw1sy30bd9B-lw3E8lg07bqEto8u-dKj5Sq4oAqGReXQSodCg2POg3ACB9fDybWGAY91aPoW3C52rpzpQnKrlFEDNf2HGg79Lrqm9iEO_Z_B5Gyw8ZD6TdekQx-bujsHfwCB0npp</recordid><startdate>20110701</startdate><enddate>20110701</enddate><creator>Gupta, Manjari</creator><creator>Ghom, Anil</creator><creator>Debta, F</creator><creator>Vyas, Sunil</creator><creator>Deoghare, Abhijeet</creator><creator>Gupta, Prashant</creator><creator>Gupta, Shantala</creator><general>Medknow Publications and Media Pvt. Ltd</general><general>Wolters Kluwer Medknow Publications</general><scope>DOA</scope></search><sort><creationdate>20110701</creationdate><title>Banned drugs: Still available in India</title><author>Gupta, Manjari ; Ghom, Anil ; Debta, F ; Vyas, Sunil ; Deoghare, Abhijeet ; Gupta, Prashant ; Gupta, Shantala</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c281t-6d1a4ea89d554cda7ff2fd36ae625d88cbe71ee61b3582d13997822c6b968c93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Banned drugs</topic><topic>Drugs</topic><topic>Mandatory drug testing</topic><topic>Pharmacovigilance</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gupta, Manjari</creatorcontrib><creatorcontrib>Ghom, Anil</creatorcontrib><creatorcontrib>Debta, F</creatorcontrib><creatorcontrib>Vyas, Sunil</creatorcontrib><creatorcontrib>Deoghare, Abhijeet</creatorcontrib><creatorcontrib>Gupta, Prashant</creatorcontrib><creatorcontrib>Gupta, Shantala</creatorcontrib><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Journal of Indian Academy of Oral Medicine and Radiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gupta, Manjari</au><au>Ghom, Anil</au><au>Debta, F</au><au>Vyas, Sunil</au><au>Deoghare, Abhijeet</au><au>Gupta, Prashant</au><au>Gupta, Shantala</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Banned drugs: Still available in India</atitle><jtitle>Journal of Indian Academy of Oral Medicine and Radiology</jtitle><date>2011-07-01</date><risdate>2011</risdate><volume>23</volume><issue>5</issue><spage>380</spage><epage>381</epage><pages>380-381</pages><issn>0972-1363</issn><eissn>0975-1572</eissn><abstract>Drugs undergo rigorous testing before they are introduced into the market. The efficacy as well as safety profiles of the drug are tested, adverse effects of drugs appear only after the drug is used in the general population. These adverse effects are detected through pharmacovigilance. If the adverse effects are severe or the risks of using the drug outweigh the benefits, the country bans the drug. Some drugs may cause adverse effects only when combined with particular drugs. In such cases, only the fixed dose combination is banned and not the individual drugs. This article is related to banned drugs and the products which are still used in medical fraternity.</abstract><pub>Medknow Publications and Media Pvt. Ltd</pub><doi>10.5005/jp-journals-10011-1174</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0972-1363
ispartof Journal of Indian Academy of Oral Medicine and Radiology, 2011-07, Vol.23 (5), p.380-381
issn 0972-1363
0975-1572
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_ed916fcf640d4bcd95cd37ac0cea3c3d
source Medknow Open Access Medical Journals(OpenAccess); Publicly Available Content Database
subjects Banned drugs
Drugs
Mandatory drug testing
Pharmacovigilance
title Banned drugs: Still available in India
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T20%3A18%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Banned%20drugs:%20Still%20available%20in%20India&rft.jtitle=Journal%20of%20Indian%20Academy%20of%20Oral%20Medicine%20and%20Radiology&rft.au=Gupta,%20Manjari&rft.date=2011-07-01&rft.volume=23&rft.issue=5&rft.spage=380&rft.epage=381&rft.pages=380-381&rft.issn=0972-1363&rft.eissn=0975-1572&rft_id=info:doi/10.5005/jp-journals-10011-1174&rft_dat=%3Cgale_doaj_%3EA745196686%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c281t-6d1a4ea89d554cda7ff2fd36ae625d88cbe71ee61b3582d13997822c6b968c93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A745196686&rfr_iscdi=true